halofantrine (Halfan)
180
relevant articles (37 outcomes,
24 trials/studies)
found for this Drug
Description:
used in treatment of mild to moderate acute malaria
Also Known As:
Halfan; 1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl; GlaxoSmithKline brand of halofantrine hydrochloride; SmithKline Beecham brand of halofantrine hydrochloride; SmithKline brand of halofantrine hydrochloride; WR 171,699; WR 171669; WR-171,669; WR-171699; halofantrine hydrochloride
Relationship Network
Drug Context: Research Results
Experts
| 1. | Falade, C O:
1 article
(12/2006)
|
| 2. | Fehintola, F A:
1 article
(12/2006)
|
| 3. | Sowunmi, A:
1 article
(12/2006)
|
| 4. | Krishna, Sanjeev:
1 article
(08/2006)
|
| 5. | Valderramos, Juan-Carlos:
1 article
(08/2006)
|
| 6. | Uhlemann, Anne-Catrin:
1 article
(08/2006)
|
| 7. | Valderramos, Stephanie G:
1 article
(08/2006)
|
| 8. | Fidock, David A:
1 article
(08/2006)
|
| 9. | Sidhu, Amar Bir Singh:
1 article
(08/2006)
|
| 10. | Ahmed, Tahir Masood:
1 article
(07/2006)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures